- Home
- GLBS vs NRSN Comparison
GLBS vs NRSN Comparison
Compare GLBS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLBS
- NRSN
- Stock Information
- Founded
- GLBS 2006
- NRSN 2017
- Country
- GLBS Greece
- NRSN Israel
- Employees
- GLBS N/A
- NRSN N/A
- Industry
- GLBS Marine Transportation
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- GLBS Consumer Discretionary
- NRSN Health Care
- Exchange
- GLBS Nasdaq
- NRSN Nasdaq
- Market Cap
- GLBS 21.9M
- NRSN 26.0M
- IPO Year
- GLBS 2007
- NRSN 2021
- Fundamental
- Price
- GLBS $1.05
- NRSN $1.18
- Analyst Decision
- GLBS Strong Buy
- NRSN Buy
- Analyst Count
- GLBS 1
- NRSN 2
- Target Price
- GLBS $3.00
- NRSN $14.00
- AVG Volume (30 Days)
- GLBS 27.3K
- NRSN 1.4M
- Earning Date
- GLBS 09-12-2025
- NRSN 09-17-2025
- Dividend Yield
- GLBS N/A
- NRSN N/A
- EPS Growth
- GLBS N/A
- NRSN N/A
- EPS
- GLBS N/A
- NRSN N/A
- Revenue
- GLBS $35,776,000.00
- NRSN N/A
- Revenue This Year
- GLBS $5.01
- NRSN N/A
- Revenue Next Year
- GLBS $27.86
- NRSN N/A
- P/E Ratio
- GLBS N/A
- NRSN N/A
- Revenue Growth
- GLBS 17.92
- NRSN N/A
- 52 Week Low
- GLBS $0.99
- NRSN $0.80
- 52 Week High
- GLBS $2.21
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- GLBS 50.05
- NRSN 46.42
- Support Level
- GLBS $1.01
- NRSN $1.14
- Resistance Level
- GLBS $1.09
- NRSN $1.28
- Average True Range (ATR)
- GLBS 0.04
- NRSN 0.15
- MACD
- GLBS 0.01
- NRSN 0.03
- Stochastic Oscillator
- GLBS 55.56
- NRSN 22.33
About GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.